MedTrace Logo

Evaluation of Clinical Decision Support System for Brain Metastasis Using Brain MR Images

NCT05573815 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 558

Last updated 2022-10-10

No results posted yet for this study

Summary

BT-M01 is a software that has been pre-learned based on a brain metastasis detection model using brain MR images, and clinical decision support system for brain metastasis by automatically analyzing brain MR images by assisting the medical team.

The specific aims of this study are to evaluate efficacy of BT-M01 for brain metastasis compared to the sensitivity and false positive rates of radiologists group.

Conditions

Interventions

DEVICE

BT-M01

Clinical decision support system for detecting brain metastasis

Sponsors & Collaborators

  • Heuron Inc.

    lead INDUSTRY

Principal Investigators

  • Ji Eun Park, M.D.pH.D · Asan Medical Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-16
Primary Completion
2022-11-30
Completion
2022-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05573815 on ClinicalTrials.gov